Clinical Trial Update: Follow-Up Evaluation for Gene-Therapy-Related Delayed Adverse Events After Participation in Pediatric Oncology Branch Clinical Trials

View source ↗

Summary

An update on follow-up evaluation for gene-therapy–related delayed adverse events in participants of pediatric oncology branch trials; the study is enrolling by…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Hematologic Malignancy
• Solid Tumor

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Pediatric Cancers, Hematologic Malignancies | Status: ENROLLING_BY_INVITATION